Acorah Software Products - Accounts Production 16.8.310 true true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 9908206 Ms Claire Harper Mr Jonathan Birkett iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 9908206 2024-12-31 9908206 2025-12-31 9908206 2025-01-01 2025-12-31 9908206 frs-core:ShareCapital 2025-12-31 9908206 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 9908206 frs-bus:AbridgedAccounts 2025-01-01 2025-12-31 9908206 frs-bus:SmallEntities 2025-01-01 2025-12-31 9908206 frs-bus:EntityHasNeverTraded 2025-01-01 2025-12-31 9908206 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 9908206 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 9908206 frs-bus:Director1 2025-01-01 2025-12-31 9908206 frs-bus:Director2 2025-01-01 2025-12-31 9908206 frs-countries:EnglandWales 2025-01-01 2025-12-31 9908206 2023-12-31 9908206 2024-12-31 9908206 2024-01-01 2024-12-31 9908206 frs-core:ShareCapital 2024-12-31
Registered number: 9908206
Eugene DNA Limited
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 December 2025
Eugene DNA Limited
Contents
Contents

| Page
--- | ---
Abridged Balance Sheet | 1
Notes to the Abridged Financial Statements | 2

Page 1
Eugene DNA Limited
Abridged Balance Sheet
As At 31 December 2025
Abridged Balance Sheet
Registered number: 9908206

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Cash at bank and in hand |  | 100 |  | 100 |
|  | 100 |  | 100 |
NET CURRENT ASSETS (LIABILITIES) |  |  | 100 |  | 100
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 100 |  | 100
NET ASSETS |  |  | 100 |  | 100
CAPITAL AND RESERVES
Called up share capital | 4 |  | 100 |  | 100
SHAREHOLDERS' FUNDS |  |  | 100 |  | 100

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 December 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board

Ms Claire Harper Director | Mr Jonathan Birkett Director
24/02/2026

The notes on page 2 form part of these financial statements.
Page 1
Page 2
Eugene DNA Limited
Notes to the Abridged Financial Statements
For The Year Ended 31 December 2025
Notes to the Abridged Financial Statements
1. General Information
Eugene DNA Limited is a private company, limited by shares, incorporated in England & Wales, registered number 9908206 . The registered office is Unit 3 Sovereign Business Park, Wyvern Ave, Stockport, SK5 7DD.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

Page 2